RNU1-143P

Across TCGA pan-cancer cohorts, RNU1-143P RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated RNU1-143P data layer.

The strongest signal is observed in esophageal carcinoma (ESCA), where higher RNU1-143P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated RNU1-143P expression acts as an unfavorable survival marker.

ESCA, UCEC, and STAD are the cancer types where RNU1-143P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.209	0.909	.004	90	view →
UCEC	OS	Tertile	III,IV	0.073	0.597	<.001	72	view →
STAD	OS	Tertile	IV	0.001	0.544	<.001	63	view →
THYM	DFS	Tertile	II,III,IV	0.145	0.873	<.001	36	view →
KIRC	DFS	Tertile	All	0.237	0.641	.002	18	view →
SKCM	DFS	Tertile	III,IV	0.058	0.648	.001	18	view →
PCPG	DFS	Tertile	All	0.161	0.819	.004	18	view →
KIRP	OS	Tertile	All	0.753	0.941	<.001	15	view →
ACC	DFS	Tertile	All	0.140	0.666	.049	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

RNU1-143P–ESCA (OS)

Open the ESCA breakdown →